1
NCLEX-RN PHARM SILVESTRI SAUNDERS COMPREHENSIVE
uE uE uE uE uE
EXAMINATION, 5TH EDITION BEST MCQS EXAM SOLUTIONS
uE uE
u E
uE uE uE uE
u E
NOTE: uETHIS uESTUDY uEGUIDE uEIS uESPECIFIC uETO uEACTUAL uE2025/26 uEEXAM
Pharmacology
uE Test uEBank
uE MULTIPLE
CHOICE
uE
1. The uEnurse uEis uEcaring uEfor uEa uEclient uEin uElabor. uEThe uEnurse uEreviews uEthe uEphysician’s uEprescriptions uEand uEnotes
uEthat
the uEclient uEhas uEa uEprescription uEfor uEbutorphanol uEtartrate uE(Stadol). uEThe uEnurse uEunderstands uEthat uEthis
uEmedication
u E u E is uEprescribed uE for:
1. Pain uErelief
2. Increasing uEuterine uEcontractions
3. Decreasing uEuterine uEcontractions
4. Promoting uEfetal uElung uEmaturity
ANS: u E 1
Rationale: uEThe uEclient uEin uElabor uEmay uEbe uEgiven uEparenteral uEanalgesia uEduring uEthe uEfirst uEstage uEof uElabor,
uEup uEto uE2 uEto uE3 uEhours uEbefore uEthe uEanticipated uEdelivery. uEButorphanol uEtartrate uEis uEa uEmedication
uEthat uEmay uEbe uEprescribed uEfor
pain uErelief. uE“Increasing uEuterine uEcontractions,” uE“decreasing uEuterine uEcontractions,” uEand uE“promoting uEfetal
lung uEmaturity” uEare uEnot uEactions uEof uEthis uEmedication.
Test-Taking uEStrategy: uEKnowledge uEof uEthe uEaction uEof uEbutorphanol uEtartrate uEis uErequired uEto uEanswer
uEthis uEquestion. uERemember uEthat uEthis uEmedication uEis uEused uEfor uEpain uErelief. uEReview uEthe uEaction uEof uEthis
uEmedication uEif uEyou uEhad uEdifficulty uEwith uEthis uEquestion uEand uEare uEunfamiliar uEwith uEthis uEmedication.
,2
PTS: 1
DIF: Level uEof uECognitive uEAbility: uEUnderstanding
REF: Lehne, uER. uE(2010). uEPharmacology uEfor uEnursing uEcare uE(7th uEed.). uESt. uELouis:
uESaunders. uEOBJ: Client uENeeds: uEPhysiological uEIntegrity
TOP: Content uEArea: uEPharmacology
MSC: uE Integrated uEProcess: uENursing uEProcess—Planning
2. The uEpostpartum uEnurse uEis uEcaring uEfor uEa uEclient uEwith uEan uEepidural uEcatheter uEin uEplace uEfor
uEopioid uEanalgesic uEadministration uEfollowing uEcesarean uEbirth. uEIf uEthe uEclient uEdevelops
uErespiratory uEdepression uEand uErequires uEnaloxone uE(Narcan) uEas uEan uEantidote, uEthe uEclient uEmay
uEcomplain uEof uEwhich uEof uEthe uEfollowing?
1. Increase uEin uEher uEpain uElevel
2. Decrease uEin uEher uEpain uElevel
3. Increase uEin uEthe uEamount uEof uEitching uEfrom uEthe uEopioid uEused uEin uEthe uEepidural
4. Decrease uEin uEthe uEamount uEof uEitching uEfrom uEthe uEopioid uEused uEin uEthe uEepidural
,3
ANS: u E 1
Rationale: uERemember uEthat uEopioids uEare uEused uEfor uEepidural uEanalgesia. uENaloxone uEis uEan uEopioid
uEantagonist, uEwhich uEreverses uEthe uEeffects uEof uEopioids. uEIf uEit uEis uEgiven, uEthe uEclient uEmay uEcomplain uEof
uEan uEincrease uEin uEher uEpain uElevel. uETherefore uE“decrease uEin uEher uEpain uElevel,” uE“increase uEin uEthe
uEamount uEof uEitching uEfrom uEthe uEopioid uEused uEin uEthe uEepidural,” uEand uE“decrease uEin uEthe uEamount uEof
uEitching uEfrom uEthe uEopioid uEused uEin uEthe uEepidural” uEare uEincorrect.
Test-Taking uEStrategy: uETo uEanswer uEthis uEquestion uEaccurately, uEyou uEmust uEknow uEthat uEopioid uEanalgesics
uEare uEthe uEmedications uEused uEwith uEepidural uEanalgesia uEto uErelieve uEpain. uETherefore uEif uEnaloxone uEis
uEadministered uEas uEan uEantidote uEfor uEan uEopioid uEanalgesic, uEthe uEclient’s uEpain uEwill uEincrease. uEReview
uEthe uEeffects uEof uEnaloxone uEif uEthis uEquestion uEwas uEdifficult.
PTS: 1
DIF: Level uEof uECognitive uEAbility: uEUnderstanding
REF: Lehne, uER. uE(2010). uEPharmacology uEfor uEnursing uEcare uE(7th uEed.). uESt. uELouis:
uESaunders. uEOBJ: Client uENeeds: uEPhysiological uEIntegrity
TOP: Content uEArea: uEPharmacology
MSC: u E Integrated uEProcess: uENursing uEProcess—Assessment
3. A uEclient uEexperiencing uEpreterm uElabor uEat uEthe uEtwenty-ninth uEweek uEof uEgestation uEhas uEbeen
uEadmitted uEto uEthe uEhospital. uEThe uEclient uEhas uEa uEprescription uEto uEreceive uEbetamethasone
uE(Celestone). uEThe uEnurse uEunderstands uEthat uEthe uEmedication uEwill uEdo uEwhich uEof uEthe uEfollowing?
1. Prevent uEspontaneous uEdelivery.
2. Stop uEthe uEuterine uEcontractions.
3. Promote uEmaturation uEof uEthe uEfetal uElungs.
4. Accelerate uEthe uEgrowth uErate uEof uEthe uEfetus.
ANS: u E 3
Rationale: uEBetamethasone uE(Celestone) uEis uEclassified uEas uEan uEanti-inflammatory uEand uEcorticosteroid.
uEIt uEincreases uEthe uEsurfactant uElevel uEand uElung uEmaturity uEin uEthe uEfetus, uEwhich uEreduces uEthe uEincidence
uEof uErespiratory uEdistress uEsyndrome. uEDelivery uEmust uEbe uEdelayed uEfor uEat uEleast uE48 uEhours uEafter
uEadministration uEof uEbetamethasone uEto uEallow uEtime uEfor uEthe uElungs uEof uEthe uEfetus uEto uEmature.
, 4
Test-Taking uEStrategy: uEOptions uEthat uEare uEcomparable uEor uEalike uEare uEnot uElikely uEto uEbe uEcorrect. uEWith
uEthis uEin uEmind, uEeliminate uE“prevent uEspontaneous uEdelivery” uEand uE“stop uEthe uEuterine uEcontractions.”
uENote uEthe uEstrategic
NCLEX-RN PHARM SILVESTRI SAUNDERS COMPREHENSIVE
uE uE uE uE uE
EXAMINATION, 5TH EDITION BEST MCQS EXAM SOLUTIONS
uE uE
u E
uE uE uE uE
u E
NOTE: uETHIS uESTUDY uEGUIDE uEIS uESPECIFIC uETO uEACTUAL uE2025/26 uEEXAM
Pharmacology
uE Test uEBank
uE MULTIPLE
CHOICE
uE
1. The uEnurse uEis uEcaring uEfor uEa uEclient uEin uElabor. uEThe uEnurse uEreviews uEthe uEphysician’s uEprescriptions uEand uEnotes
uEthat
the uEclient uEhas uEa uEprescription uEfor uEbutorphanol uEtartrate uE(Stadol). uEThe uEnurse uEunderstands uEthat uEthis
uEmedication
u E u E is uEprescribed uE for:
1. Pain uErelief
2. Increasing uEuterine uEcontractions
3. Decreasing uEuterine uEcontractions
4. Promoting uEfetal uElung uEmaturity
ANS: u E 1
Rationale: uEThe uEclient uEin uElabor uEmay uEbe uEgiven uEparenteral uEanalgesia uEduring uEthe uEfirst uEstage uEof uElabor,
uEup uEto uE2 uEto uE3 uEhours uEbefore uEthe uEanticipated uEdelivery. uEButorphanol uEtartrate uEis uEa uEmedication
uEthat uEmay uEbe uEprescribed uEfor
pain uErelief. uE“Increasing uEuterine uEcontractions,” uE“decreasing uEuterine uEcontractions,” uEand uE“promoting uEfetal
lung uEmaturity” uEare uEnot uEactions uEof uEthis uEmedication.
Test-Taking uEStrategy: uEKnowledge uEof uEthe uEaction uEof uEbutorphanol uEtartrate uEis uErequired uEto uEanswer
uEthis uEquestion. uERemember uEthat uEthis uEmedication uEis uEused uEfor uEpain uErelief. uEReview uEthe uEaction uEof uEthis
uEmedication uEif uEyou uEhad uEdifficulty uEwith uEthis uEquestion uEand uEare uEunfamiliar uEwith uEthis uEmedication.
,2
PTS: 1
DIF: Level uEof uECognitive uEAbility: uEUnderstanding
REF: Lehne, uER. uE(2010). uEPharmacology uEfor uEnursing uEcare uE(7th uEed.). uESt. uELouis:
uESaunders. uEOBJ: Client uENeeds: uEPhysiological uEIntegrity
TOP: Content uEArea: uEPharmacology
MSC: uE Integrated uEProcess: uENursing uEProcess—Planning
2. The uEpostpartum uEnurse uEis uEcaring uEfor uEa uEclient uEwith uEan uEepidural uEcatheter uEin uEplace uEfor
uEopioid uEanalgesic uEadministration uEfollowing uEcesarean uEbirth. uEIf uEthe uEclient uEdevelops
uErespiratory uEdepression uEand uErequires uEnaloxone uE(Narcan) uEas uEan uEantidote, uEthe uEclient uEmay
uEcomplain uEof uEwhich uEof uEthe uEfollowing?
1. Increase uEin uEher uEpain uElevel
2. Decrease uEin uEher uEpain uElevel
3. Increase uEin uEthe uEamount uEof uEitching uEfrom uEthe uEopioid uEused uEin uEthe uEepidural
4. Decrease uEin uEthe uEamount uEof uEitching uEfrom uEthe uEopioid uEused uEin uEthe uEepidural
,3
ANS: u E 1
Rationale: uERemember uEthat uEopioids uEare uEused uEfor uEepidural uEanalgesia. uENaloxone uEis uEan uEopioid
uEantagonist, uEwhich uEreverses uEthe uEeffects uEof uEopioids. uEIf uEit uEis uEgiven, uEthe uEclient uEmay uEcomplain uEof
uEan uEincrease uEin uEher uEpain uElevel. uETherefore uE“decrease uEin uEher uEpain uElevel,” uE“increase uEin uEthe
uEamount uEof uEitching uEfrom uEthe uEopioid uEused uEin uEthe uEepidural,” uEand uE“decrease uEin uEthe uEamount uEof
uEitching uEfrom uEthe uEopioid uEused uEin uEthe uEepidural” uEare uEincorrect.
Test-Taking uEStrategy: uETo uEanswer uEthis uEquestion uEaccurately, uEyou uEmust uEknow uEthat uEopioid uEanalgesics
uEare uEthe uEmedications uEused uEwith uEepidural uEanalgesia uEto uErelieve uEpain. uETherefore uEif uEnaloxone uEis
uEadministered uEas uEan uEantidote uEfor uEan uEopioid uEanalgesic, uEthe uEclient’s uEpain uEwill uEincrease. uEReview
uEthe uEeffects uEof uEnaloxone uEif uEthis uEquestion uEwas uEdifficult.
PTS: 1
DIF: Level uEof uECognitive uEAbility: uEUnderstanding
REF: Lehne, uER. uE(2010). uEPharmacology uEfor uEnursing uEcare uE(7th uEed.). uESt. uELouis:
uESaunders. uEOBJ: Client uENeeds: uEPhysiological uEIntegrity
TOP: Content uEArea: uEPharmacology
MSC: u E Integrated uEProcess: uENursing uEProcess—Assessment
3. A uEclient uEexperiencing uEpreterm uElabor uEat uEthe uEtwenty-ninth uEweek uEof uEgestation uEhas uEbeen
uEadmitted uEto uEthe uEhospital. uEThe uEclient uEhas uEa uEprescription uEto uEreceive uEbetamethasone
uE(Celestone). uEThe uEnurse uEunderstands uEthat uEthe uEmedication uEwill uEdo uEwhich uEof uEthe uEfollowing?
1. Prevent uEspontaneous uEdelivery.
2. Stop uEthe uEuterine uEcontractions.
3. Promote uEmaturation uEof uEthe uEfetal uElungs.
4. Accelerate uEthe uEgrowth uErate uEof uEthe uEfetus.
ANS: u E 3
Rationale: uEBetamethasone uE(Celestone) uEis uEclassified uEas uEan uEanti-inflammatory uEand uEcorticosteroid.
uEIt uEincreases uEthe uEsurfactant uElevel uEand uElung uEmaturity uEin uEthe uEfetus, uEwhich uEreduces uEthe uEincidence
uEof uErespiratory uEdistress uEsyndrome. uEDelivery uEmust uEbe uEdelayed uEfor uEat uEleast uE48 uEhours uEafter
uEadministration uEof uEbetamethasone uEto uEallow uEtime uEfor uEthe uElungs uEof uEthe uEfetus uEto uEmature.
, 4
Test-Taking uEStrategy: uEOptions uEthat uEare uEcomparable uEor uEalike uEare uEnot uElikely uEto uEbe uEcorrect. uEWith
uEthis uEin uEmind, uEeliminate uE“prevent uEspontaneous uEdelivery” uEand uE“stop uEthe uEuterine uEcontractions.”
uENote uEthe uEstrategic
